2003
DOI: 10.1124/dmd.31.3.259
|View full text |Cite
|
Sign up to set email alerts
|

CYP1A1 and CYP1B1 in Blood-Brain Interfaces: CYP1A1-Dependent Bioactivation of 7,12-Dimethylbenz(a)anthracene in Endothelial Cells

Abstract: This article is available online at http://dmd.aspetjournals.org ABSTRACT:Immunohistochemistry and autoradiography were used to identify sites of the cytochrome P450 enzymes (P450) 1A1 and 1B1 expression and activation of 7,12-dimethylbenz (

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
39
2

Year Published

2004
2004
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(45 citation statements)
references
References 37 publications
(36 reference statements)
4
39
2
Order By: Relevance
“…CYP1A2 is unlikely to be the source of the massively elevated MEL metabolite levels in the cerebral cortex. On the other hand, various elements of the mouse blood-brain barrier, including the cerebral arteries and arterioles, have been reported to have very high levels of CYP1B1 that apparently were not further inducible (Granberg et al, 2003). It is possible that CYP1B1 played a role in the sequestration of high concentrations of 6-HMEL sulfate in mouse cerebral cortex.…”
Section: Michaelis-menten Parameters Estimated For Melatonin 6-hydroxmentioning
confidence: 99%
See 1 more Smart Citation
“…CYP1A2 is unlikely to be the source of the massively elevated MEL metabolite levels in the cerebral cortex. On the other hand, various elements of the mouse blood-brain barrier, including the cerebral arteries and arterioles, have been reported to have very high levels of CYP1B1 that apparently were not further inducible (Granberg et al, 2003). It is possible that CYP1B1 played a role in the sequestration of high concentrations of 6-HMEL sulfate in mouse cerebral cortex.…”
Section: Michaelis-menten Parameters Estimated For Melatonin 6-hydroxmentioning
confidence: 99%
“…CYP1B1-mediated MEL 6-hydroxylation was then investigated in an organ that expresses CYP1B1, together with other CYP1 forms. Mouse brain was used because this organ was reported to express all three CYP1 forms (Granberg et al, 2003;Iba et al, 2003). In addition, whole brain homogenates were used for these studies in light of a report that CYP1B1 may be expressed in the nuclei of brain and other tissues (Muskhelishvili et al, 2001).…”
Section: Downloaded Frommentioning
confidence: 99%
“…Controls were incubated at 0°C. The samples were transferred to ice-cold 4% phosphate-buffered formaldehyde, pH 7, immediately after incubation and processed as described by Granberg et al (2003). The formalinfixed endometrial biopsy samples incubated with […”
Section: Methodsmentioning
confidence: 99%
“…The maintenance of the normal cellular architecture and enzyme activity makes tissue explants attractive for studies using light microscopic autoradiographic techniques to visualize cell-specific bioactivation of radiolabeled chemicals (Brittebo and Brandt, 1997). By using this approach, we have previously identified unforeseen sites of local bioactivation of chemicals in rodent extrahepatic tissues, and some potent and cell-specific toxicants have been shown (Annas and Brittebo, 1998;Granberg et al, 2003).…”
mentioning
confidence: 99%
“…In addition to MRPs, several drug-metabolizing enzymes have been shown to be expressed in the barrier including epoxide hydrolase, glutathione S-transferase, and various isoforms of the cytochrome P450 and UDPglucuronosyltransferase families (Ghersi-Egea et al, 1994;Lawrenson et al, 1999;Miksys and Tyndale, 2002;Granberg et al, 2003). Biotransformation of foreign compounds via these phase I and II enzymes might result in metabolites that can then be removed from the brain by efflux transporters such as MRPs.…”
mentioning
confidence: 99%